Related Experiment Video
Updated: Jul 28, 2026
08:42
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Regulation of osteoclast differentiation by statins
W A Grasser1, A P Baumann, S F Petras
1Department of Cardiovascular and Metabolic Diseases, Groton Laboratories, Pfizer Global Research and Development, Pfizer, Inc., Groton, CT 06340, USA.
Journal of Musculoskeletal & Neuronal Interactions
|March 11, 2005
Summary
Statins, like lovastatin, reduce osteoclast formation by inhibiting geranylgeranylation, a key process in bone metabolism. This finding helps explain how statins may influence bone health and fracture risk.
Area of Science:
- Biochemistry
- Bone Biology
- Pharmacology
Background:
- HMG-CoA reductase inhibitors (statins) are primary treatments for hyperlipidemia.
- Clinical studies suggest statins may reduce fracture risk, but the mechanism is unclear.
- The role of statins in bone metabolism and their impact on osteoclastogenesis require further investigation.
Purpose of the Study:
- To investigate the effect of statin treatment on osteoclastogenesis.
- To elucidate the specific molecular mechanisms by which statins influence bone metabolism.
Main Methods:
- Treatment of cells with lovastatin and assessment of osteoclast differentiation.
- Measurement of cholesterol biosynthesis activity.
- Evaluation of mevalonate metabolites (geranylgeraniol, squalene, farnesol) in osteoclast development.
Main Results:
- Lovastatin significantly decreased differentiated osteoclast numbers in a dose-dependent manner.
- Lovastatin inhibited cholesterol biosynthesis with an EC50 comparable to liver cells.
- Geranylgeraniol, not squalene or farnesol, was crucial for osteoclast development, indicating protein geranylgeranylation is key.
Conclusions:
- Lovastatin inhibits osteoclast development by blocking geranylgeranylation of prenylated proteins.
- Statins' effects on bone are partly mediated by their impact on osteoclast numbers.
Related Concept Videos
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...